⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT September 1, 2026

Hukyndra 80 mg Injektionslösung im Fertigpen 80 mg (Injektionslösung im Fertigpen)

📷 EU Safety Watch placeholder
Hukyndra 80 mg Injektionslösung im Fertigpen 80 mg (Injektionslösung im Fertigpen)
📷 EU Safety Watch placeholder
Hukyndra 80 mg injection solution in pre-filled pen 80 mg (injection solution in pre-filled pen) is affected.
⚠️
Shortage ongoing
ADALIMUMAB is currently in short supply in AT.
📈 Timeline
9 days active so far
September 2, 2026 September 10, 2026

What is this? Hukyndra is a medicine given by injection. It contains adalimumab, which helps reduce swelling and pain in the body.

What's happening? There is a limited supply of Hukyndra 80 mg injection pens right now. The company expects more to be available by November 30.

Does this affect me? If you use Hukyndra, your supply may be affected. Check with your pharmacist.

What should I do? Talk to your pharmacist or doctor before making any changes to your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
ADALIMUMAB
Agency-published detail

ATC: L04AB04 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of Germany · Affected packs: 1 Stück Schachtel, Fertigpen [eingeschränkt verfügbar, since 2026-09-01, resupply 2026-11-30]

First published
September 1, 2026
Last refreshed by us
14 hours ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Hukyndra 80 mg Injektionslösung im Fertigpen 80 mg (Injektionslösung im Fertigpen). Hukyndra 80 mg injection solution in pre-filled pen 80 mg (injection solution in pre-filled pen) is affected.
▸ When was this alert issued?
This alert was issued on September 1, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.